KK
LEGN icon

KLP Kapitalforvaltning’s Legend Biotech LEGN Stock Holding History

KLP Kapitalforvaltning’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.31M Buy
45,400
+27,000
+147% +$728K ﹤0.01% 988
2026
Q1 		$333K Hold
18,400
– – ﹤0.01% 1612
2025
Q4 		$400K Hold
18,400
– – ﹤0.01% 1520
2025
Q3 		$600K Hold
18,400
– – ﹤0.01% 1301
2025
Q2 		$653K Hold
18,400
– – ﹤0.01% 1206
2025
Q1 		$624K Hold
18,400
– – ﹤0.01% 1173
2024
Q4 		$599K Buy
+18,400
New +$762K ﹤0.01% 1269

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

KLP Kapitalforvaltning's LEGN Position: Q2 2026 in Review

KLP Kapitalforvaltning increased its Legend Biotech (LEGN) stake by 147% in Q2 2026, buying an estimated $728K and bringing the position to 45,400 shares worth $1.31M. The position accounts for ﹤0.01% of the portfolio, ranked #988.

KLP Kapitalforvaltning first reported a position in LEGN in Q4 2024 and has held it in 7 quarters since. 218 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • KLP Kapitalforvaltning held 45,400 shares of Legend Biotech worth $1.31M as of Q2 2026.
  • KLP Kapitalforvaltning bought 27,000 Legend Biotech shares in Q2 2026, an estimated $728K.
  • Legend Biotech made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #988 holding.
  • KLP Kapitalforvaltning first reported a position in Legend Biotech in Q4 2024 and has held it in 7 quarters since.
  • 218 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.